Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Selective measurement of anti-tTG antibodies in coeliac disease and IgA deficiency : an alternative pathway

Tools
- Tools
+ Tools

Harrison, Elizabeth, Liu, Kuo-Kang, Petchey, Michael, Nwokolo, Chuka U., Loft, Duncan and Arasaradnam, Ramesh P.. (2012) Selective measurement of anti-tTG antibodies in coeliac disease and IgA deficiency : an alternative pathway. Postgraduate Medical Journal . ISSN 0032-5473 (In Press)

[img]
Preview
Text
WRAP_Arasaradnam_Final_April 2012.pdf - Accepted Version

Download (404Kb) | Preview
Official URL: http://dx.doi.org/10.1136/postgradmedj-2011-130188

Abstract

Objective To determine the ability of selective antibody testing to screen for coeliac disease in the presence of IgA deficiency and to define the sensitivity of a pathway using this method (Figure1). Method All IgA and IgG anti-tTG tests performed at our centre between January 2008 and December 2009, using the Immunocap 250 analyser, were retrospectively reviewed. Positive results were correlated with histology. Results were used to validate our diagnostic pathway. Results 12,289 consecutive serological tests were reviewed. IgA deficient patients gave either an “error” reading or very low response on the Immunocap 250 analyser. Subsequent testing of this sub-group demonstrated raised IgG anti-tTG antibodies in those with histologically proven coeliac disease. Conclusions Using our antibody screening pathway, which involves the selective use of IgG antitTG, sensitivity increased from 87% to 92% in those with IgA deficiency. Adoption of this pathway for coeliac screening would negate the routine screening of immunoglobulin levels, with resultant cost saving.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI)
Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School > Metabolic and Vascular Health
Library of Congress Subject Headings (LCSH): Celiac disease -- Diagnosis, Immunoglobulin A, Immunoglobulin G
Journal or Publication Title: Postgraduate Medical Journal
Publisher: BMJ
ISSN: 0032-5473
Date: August 2012
Identification Number: 10.1136/postgradmedj-2011-130188
Status: Peer Reviewed
Publication Status: In Press
Access rights to Published version: Restricted or Subscription Access
References: [1] Leeds JS, Hopper AD, Sanders DS. Coeliac Disease. Br Med Bull 2008;88(1):157-70. [2] NICE clinical guideline 86. Coeliac disease: recognition and assessment of coeliac disease. [3] Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology. 2005;128(4 Suppl 1):S25-32. [4] McGowan KE, Lyon ME, Butzner JD. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem. 2008;54(7):1203-9 [5] Heneghan MA, Stevens FM, Cryan EM, et al. Celiac sprue and immunodeficiency states: a 25-year review. J Clin Gastroenterol 1997;25(2):421-5 [6] Thomas PD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea. 2nd edn. Gut 2003;52(Suppl 5):v1–v15 [7] Leffler DA, Schuppan D. Update on Serologic Testing in Celiac Disease. Am J Gastroenterol. 2010;105:2520–2524 [8] Korponay-Szabó IR, Dahlbom I, Laurila K, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut. 2003;52(11):1567-71 [9] Lenhardt A, Plebani A, Marchetti Fet al. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Dig Liver Dis. 2004;36(11):730-4 [10] Fernandez E, Blanco C, Garcia S, et al. Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected coeliac disease. Clin Chem. 2005; 51(6):1014-1016 [11] Löwbeer C, Wallinder H. Undetectable anti-tissue transglutaminase IgA antibody measured with ELISAA Celikey indicates selective IgA deficiency. Clin Chim Acta. 2010;411(7-8):612
URI: http://wrap.warwick.ac.uk/id/eprint/50135

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us